Depreciation of Aldeyra Therapeutics, Inc. from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Aldeyra Therapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • Aldeyra Therapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $60,912, a 0.46% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Depreciation for 2025 was $251,993, a 0.95% increase from 2024.
  • Aldeyra Therapeutics, Inc. annual Depreciation for 2024 was $249,623, a 5% decline from 2023.
  • Aldeyra Therapeutics, Inc. annual Depreciation for 2023 was $262,780, a 1.6% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Aldeyra Therapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $251,993 +$2,370 +0.95% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 $249,623 -$13,157 -5% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 $262,780 +$4,073 +1.6% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
2022 $258,707 -$5,473 -2.1% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 $264,180 +$207,959 +370% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $56,221 -$40,084 -42% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $96,305 +$25,302 +36% 01 Jan 2019 31 Dec 2019 10-K 11 Mar 2021 2020 FY
2018 $71,003 +$33,154 +88% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
2017 $37,849 +$2,057 +5.7% 01 Jan 2017 31 Dec 2017 10-K 08 Mar 2019 2018 FY
2016 $35,792 +$17,014 +91% 01 Jan 2016 31 Dec 2016 10-K 30 Mar 2017 2016 FY
2015 $18,778 +$17,709 +1657% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2017 2016 FY
2014 $1,069 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY

Aldeyra Therapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $60,912 +$280 +0.46% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q1 2024 $60,632 -$6,340 -9.5% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q1 2023 $66,972 +$4,231 +6.7% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q1 2022 $62,741 -$5,122 -7.5% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $67,863 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2019 $24,242 +$12,836 +113% 01 Jan 2019 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q1 2018 $11,406 +$1,746 +18% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q1 2017 $9,660 +$1,558 +19% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q1 2016 $8,102 +$6,850 +547% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q1 2015 $1,252 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.